LouBridgesMDPhD

Journal Articles

• Socioeconomic disparities in the health of African-Americans RA patients from the Southeastern USA  
  Baldassari AR, Cleveland RJ, Jonas BL, Conn DL, Moreland LW, Bridges SL Jr., Callahan LF, Arthritis Care Res, 1/22/2014
• Inhibition of terminal fucosylation reshapes human and mouse M1 macrophages and suppresses collagen II-induced arthritis  
  Li J, Hsu HC, Ding Y, Li H, Wu Q, Yang P, Luo B, Rowse AL, Spalding DM, Bridges SL Jr., Mountz JD, Arthritis Rheumatol, 1/16/2014
• Caspase-12 and rheumatoid arthritis in African-Americans  
  Marshall L, Obaidullah M, Fuchs T, Fineberg NS, Brinkley G, Mikuls TR, Bridges SL Jr. Hermel E, Immunogenetics, 1/11/2014
• Immunochip Identifies Novel and Replicates Known Genetic Risk Loci for Rheumatoid Arthritis in Black South Africans  
  Govind N, Choudhury A, Hodkinson B, Ickinger C, Frost J, Lee A, Gregersen PK, Reynolds RJ, Bridges SL Jr., Hazelhurst S, Ramsay M, Tikly M, Molecular Medicine, 1/7/2014
• Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Rheumatoid Arthritis Risk Gene  
  Okada Y, Diogo D; Denny J; Mouassess F; Achkar W; Fulton R; Denny J; Gupta N; Mirel D; Gabriel S; Li G; Kremer J; Pappas D; Carroll R; Eyler A; Trynka G; Stahl E; Cui ..., PLoS One, 1/1/2014
• Gene-body mass index interactions are linked to methotrexate toxicity in rheumatoid arthritis  
  Aslibekyan S, Sha J, Redden DT, Moreland LW, O’Dell JR, Curtis JR, Mikuls TR, Bridges SL Jr., Arnett DK, Ann Rheum Dis, 1/29/2013
• Complementary and Alternative Medicine Use in African-Americans with Rheumatoid Arthritis  
  Tamhane A, McGwin G, Redden D, Hughes LB, Brown EE, Westfall AO, Reynolds RJ, Conn DL, Jonas BL, Smith EA, Brasington RD, Moreland LW, Bridges SL, Jr., Callahan LF, Arthritis Care & Research, 1/27/2013
• Associations of alcohol use with radiographic disease progression in African-Americans with recent onset rheumatoid arthritis  
  Davis ML, Michaud K, Sayles H, Conn DL, Moreland LW, Bridges SL Jr., Mikuls TR, Journal of Rheumatology, 1/15/2013
• Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge  
  Plenge RM, Greenberg J, Mangravite L, Derry J, Stahl EA, Coenen M, Barton A, Padyukov L, Klareskog L, Gregersen PK, Mariette X, Moreland LW, Bridges SL Jr., de Vries N..., Nature Genetics, 1/1/2013
• Genetic predictors of methotrexate efficacy and toxicity in the Treatment of Early Aggressive Rheumatoid Arthritis Trial participants  
  Aslibekyan S, Brown EE, Reynolds RJ, Redden DT, Morgan SL, Baggott JE, Sha J, Moreland LW, O’Dell JR, Curtis JR, Mikuls TR, Bridges SL Jr., Arnett DK, Pharmacogenomics Journal, 1/1/2013
• Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis  
  Umicevic Mirkov M, Cui J, Vermeulen SH, Stahl EA, Toonen EJ, Makkinje RR, Lee AT, Huizinga TW, Allaart R, Barton A, Mariette X, Miceli CR, Criswell LA, Tak PP, de Vrie..., Annals of the Rheumatic Diseases, 1/1/2013
• Validation of Methotrexate-First Strategy in Early Poor Prognosis Rheumatoid Arthritis: Results from a Randomized, Double-Blind, 2-Year Trial  
  O'Dell JR, Curtis JR, Mikuls TR, Cofield SS, Bridges SL Jr., Moreland LW, for the TEAR trial Investigators, Arthritis & Rheumatism, 1/1/2013
• Ethnic-specific genetic analyses in rheumatoid arthritis: Incremental gains but valuable contributions to the big picture  
  Danila MI, Reynolds RJ, Tiwari HK, Bridges SL Jr, Arthritis & Rheumatism, 1/1/2013
• Gene Expression Patterns in Peripheral Blood Cells Associated with Radiographic Severity in African-Americans with Early Rheumatoid Arthritis  
  Reynolds RJ, Cui X, Vaughan LK, Redden DT, Causey ZL, Perkins EA, Shah T, Hughes LB, CLEAR Investigators, Damle A, Kern M, Gregersen PK, Johnson MR, Bridges SL Jr, Rheumatology International, 1/1/2013
• Changes in Lipoproteins Associated with Treatment with Methotrexate or Combination Therapy in Early Rheumatoid Arthritis: Results from the TEAR Trial  
  Navarro-Millan I, Charles-Schoeman C, Yang S, Bathon JM, Bridges SL Jr., Chen L, Cofield SS, Dell’Italia LJ, Moreland LW, O’Dell JR, Paulus HE, Curtis JR, Arthritis & Rheumatism, 1/1/2013
• Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis  
  PLoS Genetics, 1/1/2013
• Comparison of Disease Activity Score 28 using erythrocyte sedimentation rate and C-reactive protein in African-Americans with rheumatoid arthritis  
  Tamhane A, Redden DT, McGwin G, Brown EE, Westfall AO, Reynolds RJ, Hughes LB, Conn DL, Callahan LF, Jonas BL, Smith EA, Brasington RD, Moreland LW, Bridges SL, Jr, Journal of Rheumatology, 1/1/2013
• Clinical Response within 12 Weeks as a Predictor of Future Low Disease Activity in Early RA Patients: Results from the TEAR Trial  
  Curtis JR, McVie T, Mikuls TR, Reynolds RJ, Navarro-Millan IY, O’Dell JR, Moreland LW, Bridges SL Jr., Ranganath VK, Cofield SS, Journal of Rheumatology, 1/1/2013
• Genetics of rheumatoid arthritis contributes to biology and drug discovery  
  Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, Carroll RJ, Eyler AE..., Nature, 1/1/2013
• Identification of rheumatoid arthritis susceptibility loci at 1p36 and 17q12 utilizing a multi-ethnic approach  
  Kurreeman FAS, Stahl EA, Okada Y, Liao K, Diogo D, Freudenberg J, Kochi Y, Patsopoulos NA, Gupta N, CLEAR Investigators, GARNET Consortium, Klareskog L, Padyukov L, Si..., American Journal of Human Genetics, 1/1/2012
• Association of Single Nucleotide Polymorphisms (SNPs) in TAGAP and TNFAIP3 with Rheumatoid Arthritis in African Americans  
  Perkins EA, Landis D, Causey ZL, Edberg YZ, Reynolds RJ, Hughes LB, CLEAR Investigators, Kimberly RP, Edberg JC, Bridges SL Jr, Arthritis & Rheumatism, 1/1/2012
• 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-modifying Antirheumatic Drugs and Biologic Agents in the Treatment of R...  
  Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr., Chatham WW, Paulus HE, Suarez-Almazo..., Arthritis Care & Research, 1/1/2012
• Interactions of cigarette smoking with NAT2 polymorphisms impact rheumatoid arthritis risk in African Americans  
  Mikuls TR, LeVan T, Gould KA, Yu F, Thiele GM, Bynote KK, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD, Moreland LW, Reynolds RJ, Gaffo A, Bridges SL Jr, Arthritis & Rheumatism, 1/1/2012
• A Randomized Comparative Effectiveness Study of Oral Triple Therapy versus Etanercept plus Methotrexate in Early, Aggressive Rheumatoid Arthritis  
  Moreland LW, O’Dell JR, Paulus HE, Curtis JR, Bathon JM, St. Clair EW, Bridges SL, Jr., Zhang J, McVie T, Howard G, van der Heijde DM, Cofield SS, Arthritis & Rheumatism, 1/1/2012
• Serum cotinine as a biomarker of tobacco exposure is not associated with treatment response in early rheumatoid arthritis  
  Maska L, Sayles H, O'Dell JR, Curtis JR, Bridges SL Jr., Moreland LW, Cofield SS, Mikuls TR, Arthritis Care & Research, 1/1/2012
• Join now to see all

Books/Book Chapters

• Vasculitis. 
  Chapter: Chapter 1. Nomenclature and Classification of Vasculitic Syndromes. 
  Page 3 - 6Ball GV, Bridges SL JrEditors: GV Ball, BJ Fessler, and SL Bridges, Jr.Oxford University Press, Inc., New York, NYEdition 3,2014
• Oxford Textbook of Vasculitis. 
  Editors: Ball GV, Fessler BJ, and Bridges SL Jr.Oxford University Press, Inc., New York, NYEdition 3,2014
• Lippincott’s Primary Care Rheumatology. 
  Chapter: Chapter 14. Vasculitis. 
  Page 132 - 139Huynh BQN and Bridges SL JrEditors: Boulware DW and Heudebert GR.Lippincott Williams. & Wilkins, Inc., Philadelphia, PA2012
• ANCA-Associated Vasculitis. 
  Chapter: ANCA-Associated Vasculitis: Preface. 
  Fessler BJ and Bridges SL JrEditors: Fessler BJ and Bridges SL Jr., Guest Editors.Rheumatic Disease Clinics of North America2010
• Vasculitis. 
  Chapter: Chapter 7. Pathogenesis of Vasculitis. 
  Page 67 - 88Ball GV and Bridges SL JrEditors: GV Ball and SL Bridges, Jr.Oxford University Press, Inc., New York, NYEdition 2,2008
• Vasculitis. 
  Editors: Ball GV and Bridges SL Jr.Oxford University Press, Inc., New York, NYEdition 2,2008
• Arthritis and Allied Conditions 
  Chapter: Chapter 58. Rheumatoid Factor. 
  Page 1227 - 1247Bridges SL Jr. and Davidson AEEditors: WJ Koopman and LW Moreland LW.Lippincott, Williams, & Wilkins, Philadelphia, PAEdition 15,2005
• Arthritis and Allied Conditions 
  Chapter: Chapter 82. Vasculitis: Classification. 
  Page 1739 - 1744Ball GV and Bridges SL JrEditors: WJ Koopman and LW Moreland LW.Lippincott, Williams, & Wilkins, Philadelphia, PAEdition 15,2005
• Arthritis and Allied Conditions 
  Chapter: Polyarteritis Nodosa. 
  Page 1767 - 1775Ball GV and Bridges SL JrEditors: WJ Koopman and LW Moreland LW.Lippincott, Williams, & Wilkins, Philadelphia, PAEdition 15,2005
• Rheumatoid Arthritis. 
  Chapter: Chapter 17. Autoimmunity. 
  Page 197 - 212Davidson AE and Bridges SL JrEditors: BF Haynes, DS Pisetsky, and EW St. Clair.Lippincott, Williams, & Wilkins, Philadelphia, PA2004
• Rheumatology and Immunology Therapy: A to Z Essentials. 
  Chapter: Authors of 83 definitions. 
  Patel HC and Bridges SL JrEditors: Moreland LW.Springer-Verlag, Berlin, Heidelberg2004
• Conn's Current Therapy 2003. 
  Chapter: Polymyalgia Rheumatica and Giant Cell Arteritis. 
  Wimmer TG and Bridges SL JrEditors: Edward T. Bope (Author) and Robert E. Rakel.W.B. Saunders Company, New York, NY2003
• Vasculitis. 
  Chapter: Chapter 1. Classification of Vasculitis. 
  Page 1 - 4Ball GV and Bridges SL JrEditors: GV Ball and SL Bridges, Jr.Oxford University Press, Inc., New York, NYEdition 1,2002
• Modern Therapeutics in Rheumatoid Diseases. 
  Chapter: Genetic Influences on Treatment Response in Rheumatoid Arthritis. 
  Page 11 - 22Bridges SL Jr. and Kimberly RPEditors: Tsokos GC.Humana Press, Inc., Totowa, NJ2002
• Vasculitis. 
  Editors: Ball GV and Bridges SL Jr.Oxford University Press, Inc., New York, NYEdition 1,2002
• Wiley Encyclopedia of Molecular Medicine 
  Chapter: CD72. 
  Page 666 - 667Bridges SL Jr. and Kimberly RPJohn Wiley & Sons, Inc., New York, NY2002
• Vasculitis. 
  Chapter: Chapter 4. Pathogenesis of Vasculitis. 
  Page 34 - 52Ball GV and Bridges SL JrEditors: GV Ball and SL Bridges, Jr.Oxford University Press, Inc., New York, NYEdition 1,2002
• Primer on the Rheumatic Diseases. 
  Chapter: Gout: C. Treatment. 
  Page 320 - 324Bridges SL JrEditors: John Klippel.Arthritis Foundation, Atlanta, GAEdition 12,2001
• Arthritis and Allied Conditions 
  Chapter: Chapter 61. Rheumatoid Factor. 
  Page 1223 - 1244Bridges SL JrEditors: Koopman WJ.Williams and Wilkins, Baltimore, MDEdition 14,2000
• Arthritis and Allied Conditions 
  Chapter: Chapter 57. Rheumatoid Factor. 
  Page 1109 - 1130Schrohenloher RE, Bridges SL Jr., and Koopman, WJEditors: Koopman WJ.Williams and Wilkins, Baltimore, MDEdition 13,1997
• Women's Medicine 
  Chapter: Chapter 31. Rheumatoid Arthritis. 
  Page 435 - 453Bridges SL JrEditors: Blackwell, RE.Blackwell Science, Inc., Oxford, England1996
• Join now to see all

Lectures

• Toward Personalized Medicine in Rheumatoid Arthritis: The Search for Biomarkers of Treatment Response. Bilka Visiting Lecturer 
  Mayo Clinic, Rochester, MN - 1/27/2014
• Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository (TETRAD). Invited Speaker 
  NIH Campus, Building 31, Room 6C6, Bethesda, MD - 1/15/2013
• The Role of Genetics in the Pathogenesis of Rheumatoid Arthritis and its Response to Treatment. Visiting Professor 
  Changsha, China - 1/12/2013
• Rheumatoid Arthritis in African-Americans 
  Brigham and Womens Hospital, Harvard University, Boston, MA - 1/27/2012
• Getting Your First Job in Academic Rheumatology 
  1/1/2012
• Rheumatoid Arthritis in African-Americans: Lessons Learned from the CLEAR Registry 
  Emory University, Atlanta, GA - 1/1/2012
• Rheumatology Research at an Academic Medical Center: A Rewarding Career Choice. Featured Dinner Speaker 
  1/1/2012
• Personalized Medicine in Rheumatoid Arthritis. Invited Speaker 
  Quebec City, Canada - 1/29/2011
• Gout 2011: New Insights into an Old Disease 
  University of Alabama at Birmingham - 1/25/2011
• Rheumatoid Arthritis: Practical Strategies for Early Diagnosis and Tight Control 
  Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY - 1/12/2011
• Pharmacogenetics and Personalized Medicine in Rheumatoid Arthritis. Invited Speaker 
  Chicago, IL - 1/8/2011
• Rheumatoid Arthritis: Practical Strategies for Early Diagnosis and Tight Control 
  Meharry Medical College, Nashville, TN - 1/7/2011
• Genetic Influences on Disease Susceptibility and Treatment Response: Lessons Learned from Rheumatoid Arthritis 
  1/6/2011
• Academic Clinical Practice. Invited Member (One of Four Division Directors Nationally) Panel Discussion Member 
  1/4/2011
• Opportunities in Human Immunology: Rheumatoid Arthritis 
  1/22/2010
• Genetic Influences on Rheumatoid Arthritis Susceptibility and Treatment Response 
  South San Francisco, CA - 1/20/2010
• Therapeutic Strategies in Rheumatoid Arthritis 
  UAB Graduate School - 1/11/2010
• The Role of C-Reactive Protein in Rheumatoid Arthritis and Assessment of Disease Activity 
  UAB Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center, Birmingham, AL - 1/3/2010
• Genetics of Chronic Inflammatory Diseases. 
  UAB Graduate School - 1/1/2010
• Personalized Medicine in Rheumatoid Arthritis 
  Manhasset, NY - 1/28/2009
• Genetic Influences on Rheumatoid Arthritis: Susceptibility, Severity, and Response to Treatment 
  Cedars-Sinai Medical Center, Los Angeles, CA - 1/24/2009
• Genetics of Rheumatoid Arthritis: Lessons for Targeting Therapy. Visiting Professor 
  University of Nebraska Medical Center, Omaha, NE - 1/24/2009
• Genetic Influences on Rheumatoid Arthritis in African-Americans 
  University of Pittsburgh Medical Center, Pittsburgh, PA - 1/23/2009
• Pharmacogenomics in Rheumatoid Arthritis – Deciphering disease pathways through better understanding of intended and unintended drug effects. 
  New Orleans, LA - 1/18/2009
• Demystifying the NIH Grant Application Process 
  1/4/2009
• Join now to see all